FINAL RESULTS FROM THE PHASE 1B/2 STUDY (PX-171-006) OF CARFILZOMIB (CFZ) IN COMBINATION WITH LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE (CRD) FOR PATIENTS WITH RELAPSED OR PROGRESSIVE MULTIPLE MYELOMA
HAEMATOLOGICA（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要